Sars-Cov-1 Antibody

SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody

abx137719-100tests 100 tests
EUR 1237.5

Human IgG antibody Laboratories manufactures the sars-cov-1 antibody reagents distributed by Genprice. The Sars-Cov-1 Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Antibody. Other Sars-Cov-1 products are available in stock. Specificity: Sars-Cov-1 Category: Antibody

Human SARS-CoV-2 Nucleocapsid IgG (SARS-CoV-2 N IgG) ELISA Kit

100 µl
EUR 687.5

GENLISA Human SARS-CoV IgG ELISA

1 x 96 wells
EUR 302.5

CoV-2 IgG S1

50µg
EUR 900
Description: Recombinant Anti Human SARS CoV-2 IgG Spike S1

CoV-2 IgG ELISA

96 tests
EUR 758
Description: IgG Screening ELISA

CoV-2 IgG+ ELISA

24 x 4 tests
EUR 948
Description: IgG+ Confirmatory ELISA

True Blue

5.0mg
EUR 595

True Blue

5(mg
EUR 635

Chemicals information

SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb

MBS8119476-5x01mL 5x0.1mL
EUR 2010

SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb

MBS8119477-002mL 0.02mL
EUR 210

SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb

MBS8119477-01mL 0.1mL
EUR 480

SARS-CoV/SARS-CoV-2 Spike antibody,Chimeric MAb

MBS8119477-5x01mL 5x0.1mL
EUR 2010

SARS-CoV/SARS-CoV-2 Spike Antibody,Chimeric MAb

MBS8119480-002mL 0.02mL
EUR 210

SARS-CoV/SARS-CoV-2 Spike Antibody,Chimeric MAb

MBS8119480-01mL 0.1mL
EUR 480

SARS-CoV/SARS-CoV-2 Spike Antibody,Chimeric MAb

MBS8119480-5x01mL 5x0.1mL
EUR 2010

SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb

MBS8110617-002mL 0.02mL
EUR 210

SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb

MBS8110617-01mL 0.1mL
EUR 480

SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb

MBS8110617-5x01mL 5x0.1mL
EUR 2010

SARS-CoV/SARS-CoV-2 Spike Antibody, Chimeric MAb

MBS8574846-01mg 0.1mg
EUR 705

SARS-CoV/SARS-CoV-2 Spike Antibody, Chimeric MAb

MBS8574846-5x01mg 5x0.1mg
EUR 2910

SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb

MBS8574847-01mg 0.1mg
EUR 705

SARS-CoV/SARS-CoV-2 Spike antibody, Chimeric MAb

MBS8574847-5x01mg 5x0.1mg
EUR 2910

SARS-CoV-2 (COVID-19) NSP7 Antibody

9155-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers.

SARS-CoV-2 (COVID-19) NSP7 Antibody

9155-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers.

SARS-CoV-2 (COVID-19) NSP8 Antibody

9159-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6).